A structured clinical decision support tool for cardiovascular risk stratification and longitudinal monitoring during anthracycline and HER2-targeted therapy
Translating the 2022 ESC cardio-oncology recommendations into a structured clinical decision support tool may facilitate standardized cardiovascular assessment and risk-adapted monitoring in patients receiving potentially cardiotoxic cancer therapy. To develop and present a structured clinical decision sup...